| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |